While EPAC1 reduces cell proliferation in A498 clear renal cell carcinoma (cRCC) cells [140], it promotes cell proliferation and survival in prostate cancer cells by upregulating Ras/MAPK and PI3K/Akt/mTOR signaling [141,142,143]. This evidence concerns the gene RAPGEF3 and prostate carcinoma.